Additional file 1 of The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”

Tauziède-Espariat, Arnault; Pierron, Gaëlle; Siegfried, Aurore; Guillemot, Delphine; Uro-Coste, Emmanuelle; Nicaise, Yvan; Castel, David; Catalaa, Isabelle; Larrieu-Ciron, Delphine; Chaynes, Patrick; de Barros, Amaury; Nicolau, Julien; Gareton, Albane; Lechapt, Emmanuèle; Chrétien, Fabrice; Bourdeaut, Franck; Doz, François; Bouchoucha, Yassine; Grill, Jacques; Beccaria, Kévin; Boddaert, Nathalie; Saffroy, Raphaël; Pagès, Mélanie; Varlet, Pascale

doi:10.6084/m9.figshare.14433416.v1

40478_2020_1064_MOESM1_ESM.docx (15.55 kB)

Additional file 1 of The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”

journal contribution

posted on 2021-04-16, 10:52 authored by Arnault Tauziède-Espariat, Gaëlle Pierron, Aurore Siegfried, Delphine Guillemot, Emmanuelle Uro-Coste, Yvan Nicaise, David Castel, Isabelle Catalaa, Delphine Larrieu-Ciron, Patrick Chaynes, Amaury de Barros, Julien Nicolau, Albane Gareton, Emmanuèle Lechapt, Fabrice Chrétien, Franck Bourdeaut, François Doz, Yassine Bouchoucha, Jacques Grill, Kévin Beccaria, Nathalie Boddaert, Raphaël Saffroy, Mélanie Pagès, Pascale Varlet

Additional file 1: Table S1. Immunohistochemical findings of our cases of HGNET-BCOR with EP300:BCOR fusion.